TETRAPHASE PHARMACEUTICALS INC·4

Jan 19, 7:48 PM ET

Unninayar Kamalam 4

4 · TETRAPHASE PHARMACEUTICALS INC · Filed Jan 19, 2018

Insider Transaction Report

Form 4
Period: 2018-01-17
Unninayar Kamalam
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Unit

    2018-01-17+40,00040,000 total
    Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
  • [F2]These restricted stock units shall be earned upon achievement of certain performance conditions and, if earned, shall vest on January 31, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION